Search

everythinglearnresearchcommunity

for

Search:↓

The case shows how hard it is to tell apart Multiple Autoimmune Syndrome from other similar autoimmune conditions, but correct diagnosis is key for treatment to work.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Autoimmune markers may help diagnose and manage PCOS.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Alopecia areata may be caused by antibodies targeting specific hair follicle proteins, hindering hair growth.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

Testing for various autoantibodies in Indian children with lupus can help predict disease symptoms and risks.

Local inflammation worsens autoimmune skin conditions by increasing antibody buildup.

Distinct miRNA signatures could help diagnose and treat severe Alopecia Areata.

People with alopecia areata have different blood markers that suggest inflammation and immune system issues compared to healthy individuals.

Hair loss treatment caused more hair loss in a man.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

Anti-Desmocollin 3 antibodies can cause atypical pemphigus symptoms.

Bacteroides fragilis and Microbacterium sp. T32 may be linked to autoimmune activity in Hashimoto's thyroiditis and alopecia areata.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

miR-155 levels in blood could help identify alopecia areata.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Autoimmune Polyendocrine Syndromes involve specific combinations of endocrine and non-endocrine autoimmune diseases.

Most patients with dermatomyositis had skin rash and were treated with prednisolone and hydroxychloroquine.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

The muscle damage was caused by T-cell large granular lymphocytic leukemia, not dermatomyositis.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Alopecia areata is linked to autoimmune antibodies.

Mast cells and the CB1 receptor may be key in causing IgA vasculitis.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.